Data / Form D filings / KP BIOSCIENCES, INC.
KP BIOSCIENCES, INC.: Form D filings
KP BIOSCIENCES, INC., a pharmaceuticals company in Orem, UT, filed 3 Form D notices with the SEC between 2016 and 2018. The latest, on January 11, 2018, reports $50,000 sold of a $1 million offering to 1 investor.
Find out what KP BIOSCIENCES, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1372 SOUTH 740 EAST, Orem, UT, 84097
- Phone
- (281) 832-0050
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1661058
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 11, 2018 | New notice | $1,000,000 | $50,000 | $950,000 | 1 | Jan 2, 2018 | sec.gov |
| Feb 2, 2017 | Amendment | $1,225,000 | $280,000 | $945,000 | 3 | Jan 6, 2016 | sec.gov |
| Jan 6, 2016 | New notice | $1,225,000 | $0 | $1,225,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marc Hansen | Executive Officer | |
| Steve Smith | Director | |
| Mark Elder | Executive Officer | |
| Matthew Cryer | Executive Officer, Director | |
| Kyle Lane | Executive Officer, Director |
Every Form D from the week of Jan 8, 2018 · All recent filings in Utah · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what KP BIOSCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.